首页> 外国专利> Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

机译:用过敏性鼻炎治疗转基因睾酮生物粘附性凝胶制剂的性腺抑制剂的方法,以及预防过敏性鼻炎事件的方法

摘要

The present invention relates to methods of treating hypogonadism in a male subject through administering intranasally to the male subject an intranasal testosterone bio-adhesive gel formulation to deliver a therapeutically effective amount of testosterone. In particular, the testosterone therapy of the invention remains effective if an allergic rhinitis event occurs in the male during the treatment or when the male subject uses a topical nasal vasoconstrictor or a topical intranasal decongestant during the hypogonadism treatment. Further, the present invention relates to a method of preventing the occurrence of an allergic rhinitis event in a male, who is undergoing a hypogonadism treatment with an intranasal testosterone bio-adhesive gel. In certain embodiments, the intranasal testosterone bio-adhesive gel formulation according to the invention comprises 4.0% and 4.5% testosterone.
机译:本发明涉及通过向男性对象鼻内给予鼻内睾酮生物粘合剂凝胶制剂来治疗男性受试者中性腺后性腺的方法,以提供治疗有效量的睾酮。 特别地,本发明的睾酮治疗如果在治疗期间发生过敏性鼻炎事件或者当男性受试者在性腺治疗期间使用局部鼻腔血管基血管生成剂或局部鼻内减振剂时,本发明的睾酮治疗仍然有效。 此外,本发明涉及预防雄性后病症的过敏性鼻炎事件的方法,该方法是用鼻内睾酮生物粘合剂凝胶进行过低组织治疗。 在某些实施方案中,根据本发明的鼻内睾酮生物粘合剂凝胶制剂包含4.0%和4.5%的睾酮。

著录项

  • 公开/公告号US11090312B2

    专利类型

  • 公开/公告日2021-08-17

    原文格式PDF

  • 申请/专利权人 ACERUS BIOPHARMA INC.;

    申请/专利号US202016905610

  • 发明设计人 NATALIA TKACHENKO;

    申请日2020-06-18

  • 分类号A61K31/56;A61K31/568;A61P15;A61P37/08;A61K9;A61K31/4174;

  • 国家 US

  • 入库时间 2022-08-24 20:38:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号